Lung Kee widens annual loss as revenue falls but posts positive comprehensive income

Lung Kee (Bermuda) Holdings Limited ( (HK:0255) ) has shared an announcement.

Lung Kee Group Holdings Limited reported a decline in full-year 2025 revenue to HK$1.32 billion from HK$1.55 billion in 2024, reflecting softer demand and pressure on its core manufacturing operations. The group’s loss for the year widened to HK$22.6 million, although various cost controls narrowed expenses across materials, staff, and other operating items.

Despite the larger loss, total comprehensive income turned positive at HK$38.1 million in 2025, helped by a sizeable exchange gain from the translation of foreign operations. Basic and diluted loss per share increased to 3.58 Hong Kong cents, signalling weaker earnings for shareholders and underscoring continued operating headwinds for the mould manufacturing group.

The most recent analyst rating on (HK:0255) stock is a Hold with a HK$1.50 price target. To see the full list of analyst forecasts on Lung Kee (Bermuda) Holdings Limited stock, see the HK:0255 Stock Forecast page.

More about Lung Kee (Bermuda) Holdings Limited

Lung Kee Group Holdings Limited is a Hong Kong-listed industrial group incorporated in Bermuda that operates in the manufacturing sector. The company primarily produces mould bases and related products for the mould and die industry, serving manufacturers that supply components and tooling to a wide range of downstream industries in Asia and globally.

Average Trading Volume: 86,189

Technical Sentiment Signal: Hold

Current Market Cap: HK$893.8M

Find detailed analytics on 0255 stock on TipRanks’ Stock Analysis page.